jscreen, TODAY Show & Mount Sinai Unite for Groundbreaking Cancer Genetic Screening Event in Honor of Breast Cancer Awareness Month

NEW YORK, Oct. 3, 2025 /PRNewswire/ -- To honor Breast Cancer Awareness Month, jscreen.org, a national nonprofit that provides accessible genetic testing, partnered with Myriad Genetics and Mount Sinai Cancer Center, hosted a historic event on Rockefeller Plaza: Pink Power Hour. Here, 350 participants gathered for the most people ever to sign up for genetic screening in one hour.

Due to the generosity of jscreen's funders and Mount Sinai's supporters, the 350 hereditary cancer screening tests were fully covered for participants who registered on-site at the TODAY Show Plaza.

This initiative cast a powerful national spotlight on the importance of genetic testing, prevention, and early detection. By arming people with knowledge about their inherited cancer risks it underscored how proactive health decisions can prevent cancer and save lives.

The goal of this high-profile event was not only to gather hundreds to register for genetic cancer testing in one hour, but also to create a nationwide ripple effect, encouraging individuals and families everywhere to take advantage of hereditary cancer testing through jscreen.

With simple, at-home hereditary cancer test kits provided on site, jscreen empowers participants with life-saving knowledge about their genetic risks for cancer related to mutations in BRCA1, BRCA2, and dozens of other cancer genes. For jscreen, a nonprofit funded by donations and partnerships, this investment underscores a deep commitment to raising awareness about the power of genetic testing as a proactive health tool.

"Knowledge is power when it comes to health. We are proud to remove barriers and provide this opportunity during Breast Cancer Awareness Month," said Dr. Matt Goldstein, CEO of jscreen. "This monumental event, where 350 gathered in one location in one hour, allows us to demonstrate how one simple test can change and even save lives."

The event also featured breast cancer advocate and TODAY Show contributor Jill Martin, who has courageously shared her personal journey to highlight the importance of genetic testing and early detection, as well as Dr. Elisa Port, Chief Breast Surgeon at Mount Sinai. Together with TODAY, Mount Sinai, and Jill Martin, jscreen continues to turn pain into purpose, creating a movement of empowerment, prevention, and proactive health.

The Event Was A Powerful Partnership for Public Health

• jscreen – As a national nonprofit, jscreen works to expand access to high-quality hereditary cancer and reproductive genetic testing through education, outreach, at-home testing, and telehealth genetic counseling services. CEO Dr. Matt Goldstein, Executive Director and Genetic Counselor Karen Grinzaid, together with several members of the jscreen team were on-site to guide attendees and provide resources.
  
  
• NBC's TODAY Show – America's most-watched morning show brought unmatched reach to millions of households nationwide. Through on-air and digital coverage, TODAY helped raise awareness of hereditary cancer risks and inspired viewers to pursue genetic testing.
  
  
• Mount Sinai Cancer Center – One of the nation's premier cancer institutions, Mount Sinai helped to underwrite the cost of screenings on the Plaza through philanthropic support. Dr. Elisa Port, alongside a team of genetic counselors, provided expertise and educated the public on the lifesaving role of early detection.
  
  
• Nationwide Access – Viewers across the U.S. can access testing by visitingwww.jscreen.org for cancer genetic testing using Myriad Genetics' MyRisk® Hereditary Cancer Test.

About jscreen

jscreen is a national nonprofit public health initiative dedicated to preventing hereditary cancers and genetic diseases through accessible education, at-home screening kits, and expert counseling. By making testing affordable and simple, jscreen empowers individuals and families to take proactive steps toward healthier futures. Learn more at www.jscreen.org.

About Myriad Genetics

Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being. Myriad develops and offers genetic tests that help assess the risk of developing disease, guide treatment decisions, and improve patient care while lowering healthcare costs. Together with jscreen, Myriad aims to expand nationwide access to high-quality hereditary cancer and reproductive genetic testing. For more information, visit www.myriad.com.

About Mount Sinai Health System

The Mount Sinai Health System is one of the largest and most respected academic medical systems in the New York metro area, renowned for excellence in patient care, medical education, and groundbreaking research. Mount Sinai's Tisch Cancer Institute and affiliated programs provide world-class expertise in cancer prevention, screening, and treatment. Learn more at www.mountsinai.org.

Media Contact:
Stacey Bender
973-650-1218
[email protected] 

SOURCE jscreen